Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Allogene Therapeutics (ALLO) Interest Coverage Ratio (2024 - 2025)

Allogene Therapeutics (ALLO) has disclosed Interest Coverage Ratio for 2 consecutive years, with 135.48 as the latest value for Q4 2025.

  • Quarterly Interest Coverage Ratio rose 81.86% to 135.48 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 194.71 through Dec 2025, up 87.1% year-over-year, with the annual reading at 194.71 for FY2025, 87.1% up from the prior year.
  • Interest Coverage Ratio hit 135.48 in Q4 2025 for Allogene Therapeutics, down from 130.53 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 130.53 in Q3 2025 to a low of 746.79 in Q4 2024.